Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HAIC”

212 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 212 results

Not applicableNot Yet RecruitingNCT07618546
What this trial is testing

A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors

Who this might be right for
HCC - Hepatocellular Carcinoma
Henan Cancer Hospital 208
Testing effectiveness (Phase 2)Looking for participantsNCT06812039
What this trial is testing

HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Fudan University 165
Testing effectiveness (Phase 2)UnknownNCT05214339
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET)

Who this might be right for
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma by BCLC Stage
Sun Yat-sen University 30
Large-scale testing (Phase 3)Looking for participantsNCT05476432
What this trial is testing

HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 300
Testing effectiveness (Phase 2)Looking for participantsNCT06904014
What this trial is testing

Efficacy and Safety of Sintilimab Combined With Lenvatinib and HAIC for Neoadjuvant Therapy of Borderline Resectable HCC

Who this might be right for
HCC
Lei ZHAO 40
Large-scale testing (Phase 3)Looking for participantsNCT06172205
What this trial is testing

Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC

Who this might be right for
BCLC Stage C Hepatocellular CarcinomaChemotherapy Effect
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 262
Large-scale testing (Phase 3)UnknownNCT04667351
What this trial is testing

HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353827
What this trial is testing

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Hepatic Arterial Infusion Chemotherapy
Sun Yat-sen University 36
Testing effectiveness (Phase 2)Looking for participantsNCT05954897
What this trial is testing

Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Guangdong Provincial People's Hospital 29
Testing effectiveness (Phase 2)UnknownNCT05511051
What this trial is testing

A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy

Who this might be right for
Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07685535
What this trial is testing

HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Liver Cancer
Shanghai Zhongshan Hospital 29
Testing effectiveness (Phase 2)Looking for participantsNCT06363825
What this trial is testing

TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Fujian Medical University 57
Post-approval studies (Phase 4)Not Yet RecruitingNCT06311916
What this trial is testing

Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.

Who this might be right for
HCC
Chen Xiaoping 312
Not applicableLooking for participantsNCT06643208
What this trial is testing

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fujian Provincial Hospital 37
Not applicableNot Yet RecruitingNCT06823050
What this trial is testing

A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC

Who this might be right for
Hepatocellular Carcinoma
Xuhua Duan 59
Testing effectiveness (Phase 2)UnknownNCT02987699
What this trial is testing

Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 54
Testing effectiveness (Phase 2)Study completedNCT05166239
What this trial is testing

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Peking University 66
Not applicableUnknownNCT03591705
What this trial is testing

TACE-HAIC vs. HAIC for Potentially Resectable HCC

Who this might be right for
Potentially ResectionHepatocellular Carcinoma
Sun Yat-sen University 240
Testing effectiveness (Phase 2)UnknownNCT05400902
What this trial is testing

HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Binkui Li 17
Not applicableUnknownNCT05788835
What this trial is testing

DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial

Who this might be right for
HCC
Xuhua Duan 220
Next Page